How do I buy shares of Oncology Pharma? Shares of ONPHD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
How much is oncology stock?
What is Oncology Pharma's stock price today? One share of ONPHD stock can currently be purchased for approximately $3.99.
Should you buy onph stock?
The capital outlay is projected to be significantly lower than traditional drug development programs and there is a high need for improved therapies for patients with rare cancers with the potential for Oncology Pharma to positively impact these patients worldwide.
Is onph a strong buy?
If you are looking for stocks with good return, Oncology Pharma Inc can be a profitable investment option. Oncology Pharma Inc quote is equal to 6.710 USD at 2022-02-18. Based on our forecasts, a long-term increase is expected, the "ONPH" stock price prognosis for 2027-02-12 is 48.621 USD.
Is onph a buy now?
There are mixed signals in the stock today. The Oncology Pharma Inc. stock holds a buy signal from the short-term moving average; at the same time, however, the long-term average holds a general sell signal.
Is Oncology Pharma a good stock buy?
If you are looking for stocks with good return, Oncology Pharma Inc stock can be a bad, high-risk 1-year investment option. Oncology Pharma Inc real time quote is equal to 1.880 USD at 2022-06-03, but your current investment may be devalued in the future.
Who owns Oncology Pharma?
Marcel van HeesewijkDescription Oncology Pharma Inc. The company was founded by Marcel van Heesewijk on March 26, 1993 and is headquartered in San Francisco, CA.
What is the price of Oncology Pharma Incorporated?
2.0600(ONPH) Stock Price, News, Quote & History - Yahoo Finance....Performance Outlook.Previous Close2.0600Day's Range1.9400 - 2.090052 Week Range1.4700 - 38.2500Volume96,902Avg. Volume78,3803 more rows
Is Oncology Pharma a real company?
Oncology Pharma Inc. operates as an oncology company. The Company focuses on developing, manufacturing, and commercialization of therapeutics for cancer patients.
WHAT IS Pharma oncology?
Oncology drugs are therapeutics used to treat cancer, a group of diseases caused by uncontrolled growth and division of abnormal cells. Oncology drugs include a range of different types of medications, such as chemotherapy agents, targeted therapies, immunotherapies, and hormone therapies.
What does ONPH company do?
ABOUT ONCOLOGY PHARMA, INC. (OTC PINK:ONPH) (the 'Company') is currently engaging in research and development of therapeutics for oncology and prides itself for having a world-class Advisory Board that keeps the Company in the forefront of developing technologies in cancer research, biotechnology, and healthcare.
How do I invest in oncology pharma?
You can buy Oncology Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Does oncology pharma pay dividends?
Oncology Pharma (ONPH) does not pay a dividend.
Does ONPH stock pay dividends?
ONPH does not currently pay a dividend.
Is ONPH an OTC stock?
ONPH | Oncology Pharma Inc. Stock Overview (U.S.: OTC) | Barron's.
Is ONPH on Nasdaq?
Oncology Pharma (ONPH) Stock Price, Quote, News & History | Nasdaq.
What did oncology pharmacy close at today?
As of June 15 11:14AM EDT. Market open....Performance Outlook.Previous Close1.500052 Week Range1.4700 - 37.7600Volume31,778Avg. Volume62,3514 more rows
How has Oncology Pharma's stock performed in 2022?
Oncology Pharma's stock was trading at $4.05 on January 1st, 2022. Since then, ONPH stock has decreased by 54.3% and is now trading at $1.85. View...
Who are Oncology Pharma's key executives?
Oncology Pharma's management team includes the following people: Mr. Chuck Wagner , Pres, Treasurer & Chairman Mr. George Malesek , Interim Chie...
Who are some of Oncology Pharma's key competitors?
Some companies that are related to Oncology Pharma include IronNet (IRNT) , MiX Telematics (MIXT) , Kaltura (KLTR) , Ventoux CCM Acquisition (V...
What is Oncology Pharma's stock symbol?
Oncology Pharma trades on the OTCMKTS under the ticker symbol "ONPH."
How do I buy shares of Oncology Pharma?
Shares of ONPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBul...
What is Oncology Pharma's stock price today?
One share of ONPH stock can currently be purchased for approximately $1.85.
How much money does Oncology Pharma make?
Oncology Pharma (OTCMKTS:ONPH) has a market capitalization of $62.46 million.
How many employees does Oncology Pharma have?
Oncology Pharma employs 1 workers across the globe.
What is Oncology Pharma's official website?
The official website for Oncology Pharma is www.oncology-pharma.com .
How has Oncology Pharma's stock price performed in 2022?
Oncology Pharma's stock was trading at $4.05 at the start of the year. Since then, ONPHD stock has decreased by 61.2% and is now trading at $1.57....
Who are Oncology Pharma's key executives?
Oncology Pharma's management team includes the following people: Mr. Chuck Wagner , Pres, Treasurer & Director Dr. Vijay Mahant , COO & Chief Sc...
Who are some of Oncology Pharma's key competitors?
Some companies that are related to Oncology Pharma include Liquid Media Group (YVR) , FalconStor Software (FALC) , hopTo (HPTO) , Destiny Media...
What is Oncology Pharma's stock symbol?
Oncology Pharma trades on the OTCMKTS under the ticker symbol "ONPHD."
How do I buy shares of Oncology Pharma?
Shares of ONPHD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBu...
What is Oncology Pharma's stock price today?
One share of ONPHD stock can currently be purchased for approximately $1.57.
How much money does Oncology Pharma make?
Oncology Pharma (OTCMKTS:ONPHD) has a market capitalization of $2.46 million.
What is Oncology Pharma's official website?
The official website for Oncology Pharma is www.oncology-pharma.com .
How can I contact Oncology Pharma?
Oncology Pharma's mailing address is 16855 WEST BERNARDO DRIVE SUITE 260, SAN DIEGO CA, 92127 . The company can be reached via phone at 415-869-1...
Oncology Pharma Expands on Feasibility Studies and Data
SAN FRANCISCO, CA / ACCESSWIRE / February 17, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc.
Oncology Pharma, Inc. and Regen BioPharma, Inc. Announce Intent to Jointly Fast Track Development of Modified mRNA anti-Cancer Vaccine
SAN FRANCISCO, CA / ACCESSWIRE / February 14, 2022 / Oncology Pharma, Inc. ("The Company") (OTC PINK:ONPH) and Regen BioPharma, Inc.
Oncology Pharma Gives Update on Technology, Formulation and Data Creation
SAN FRANCISCO, CA / ACCESSWIRE / February 8, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc.
Oncology Pharma's New Year Update
SAN FRANCISCO, CA / ACCESSWIRE / January 10, 2022 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc.
Oncology Pharma Meeting Towards Future Developments
SAN FRANCISCO, CA / ACCESSWIRE / December 17, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) Oncology Pharma, Inc.
Oncology Pharma Year End Review and Outlook
SAN FRANCISCO, CA / ACCESSWIRE / December 9, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc.
Oncology Pharma Research and Vision
SAN FRANCISCO, CA / ACCESSWIRE / November 30, 2021 / Oncology Pharma Inc. (OTC PINK:ONPH) - Oncology Pharma, Inc.
About Oncology Pharma
Oncology Pharma Inc., an oncology company, develops, manufactures, and commercializes therapeutics. The company has a collaboration and licensing agreement with Kalos Therapeutics Inc. for exploring treatment opportunities of the COVID-19 virus. The company was formerly known as SourcingLink.net Inc. and changed its name to Oncology Pharma Inc.
Who are some of Oncology Pharma's key competitors?
Some companies that are related to Oncology Pharma include Qumu (QUMU), Advanced Human Imaging (AHI), GSE Systems (GVP), Safe-T Group (SFET), Infobird (IFBD), Intellinetics (INLX), Taoping (TAOP), Amesite (AMST), Bridgeline Digital (BLIN), FalconStor Software (FALC), UMeWorld (UMEWF), Mmtec (MTC), Destiny Media Technologies (DSNY), FalconStor Software (FALCD) and Cyren (CYRN). View all of ONPHD's competitors..
What is Oncology Pharma's stock symbol?
Oncology Pharma trades on the OTCMKTS under the ticker symbol "ONPHD."
How do I buy shares of Oncology Pharma?
Shares of ONPHD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
What is Oncology Pharma's stock price today?
One share of ONPHD stock can currently be purchased for approximately $5.36.
Where are Oncology Pharma's headquarters?
Oncology Pharma is headquartered at 16855 WEST BERNARDO DRIVE SUITE 260, SAN DIEGO CA, 92127.
No. 6 AstraZeneca
AstraZeneca is an oncology stock that provides treatment options for many medical areas. Along with oncology, it produces therapies for issues with the heart, lungs and immune system.
No. 5 Merck & Co
Merck is an oncology stock with an even better dividend yield than AstraZeneca. At almost 3.5%, you could make some great income flow. But, when you have a high dividend yield, you must make sure the company is financially sound.
No. 4 AbbVie Inc
AbbVie has a huge market cap of about $242 billion. It’s a steady and slow-growing stock, with visions for the future.
No. 3 Eli Lilly and Company
This oncology stock has a large market cap, too. It’s at almost $250 billion.
Oncology Stocks No. 2 Gilead Sciences, Inc
The market cap of this oncology stock is bit smaller than most of the others on this list. However, that’s not a bad thing. In fact, it sits just above $90 billion.
Oncology Stocks No. 1 Pfizer Inc
Pfizer’s net profit margins and revenues are up by triple digits. It was founded in 1849. And now, it has a market cap of over $314 billion.
Oncology Pharma (ONPH)
This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.
Chart for ONPH
Oncology Pharma Inc. is engaged in developing, manufacturing and commercializing therapeutics. The Company licensed Tulynode's patent pending Autologous Immuno-therapy for durable therapy response using an extracorporeal device. Oncology Pharma Inc., formerly knonw as SourcingLink.net Inc., is based in San Francisco, California.
How to invest in oncology stocks?
Invest in the oncology stocks now with a market order or use a limit order to delay your purchase until the stock reaches your desired price. Buy the stock. Tap or click the Buy button on your brokerage account. Once you’ve invested in the cancer industry, track how your stock performs to decide when it’s time to sell.
What is Amgen stock?
discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology and neuroscience areas. Amgen stock opened the day at $243.09 after a previous close of $244.28.
What is Five Prime Therapeutics?
Five Prime Therapeutics, Inc. , a clinical-stage biotechnology company, focuses on the development of immuno-oncology and targeted cancer therapies . The company's product candidates comprise Bemarituzumab, an antibody that inhibits fibroblast growth factor receptor 2b, or FGFR2b to treat patients with gastric or gastroesophageal junction and GEJ cancer; FPT155, a soluble CD80 fusion protein that enhances co-stimulation of T cells through CD28 that is in Phase Ia/1b clinical trial for patients with solid tumors; and BMS-986258, an anti-T cell immunoglobulin and mucin domain-3 antibody, which is in Phase I/II clinical trial in combination with Opdivo in patients with advanced malignant tumors.
What is the company that makes Revlimid?
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. The company offers products in hematology, oncology, cardiovascular, and immunology therapeutic classes. Its products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Opdivo for anti-cancer indications; Eliquis, an oral inhibitor indicated for the reduction in risk of stroke/systemic embolism in NVAF, and for the treatment of DVT/PE; and Orencia for adult patients with active RA and psoriatic arthritis, as well as reducing signs and symptoms in pediatric patients with active polyarticular juvenile idiopathic arthritis.
What is Cardiff Oncology?
Cardiff Oncology, Inc. , a clinical-stage biotechnology company, develops drugs for the treatment of cancer . Its lead drug candidate is onvansertib, a Polo-like Kinase 1 selective adenosine triphosphate competitive inhibitor that is in Phase Ib/II clinical trial in acute myeloid leukemia (AML); has completed a Phase I clinical trial in advanced solid tumors; and Phase Ib/II clinical trial for metastatic colorectal cancer in combination with FOLFIRI and Avastin.
Can you turn a profit on oncology stocks?
While it’s possible to turn a profit investing in oncology stocks, keep in mind that — like any investment — oncology stocks are not immune to risk. These stocks are subject to fluctuating conditions — both in the market and in the cancer industry, so carefully vet your picks before you invest.
ONPH Target Price
ONPH price target in 14 days: 7.587 USD* upside and 4.783 USD* downside. (Highest and lowest possible predicted price in a 14 day period)
Oncology Pharma Inc ( ONPH ) Stock Market info
Recommendations: Buy or sell Oncology Pharma stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the Oncology Pharma share forecasts, stock quote and buy / sell signals below.
Oncology OTC Stock Historical Chart
Most investors accept the general idea that the market moves back and forth in trends. These trends are simply referred to as bull and bear market cycles. Each bull market begins after a day that signals the beginning of a new uptrend, whereas every bear market starts after the long-term downward trend is projected forward.
Oncology Pharma Investment Analysis Tools
This is a quick snapshot of Oncology Pharma research areas. You can expand your research by examining different market driven as well as company-specific characteristics using powerful cross-assets modules such as watchlist analyzer, correlation inspector, opportunity browser, portfolio optimizer and many other powerfull tools.
Use Investing Themes to Complement your positions
In addition to having Oncology Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes.
